Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-13 2023-11-06 198525
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-20 2023-11-06 207716
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-11-06 2023-11-24 209348
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2017-05-16 2017-10-05 10403
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2021-04-30 2021-05-26 138346
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-01-09 2019-03-16 71668
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-03-27 2019-04-26 79583
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-05-15 2019-08-19 84125
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-06-12 2019-08-19 86282
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-09-04 2019-12-19 92981
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-12-22 2024-02-02 214215
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2024-04-19 2024-05-03 225761
APO-LATANOPROST 50MCG SOLUTION Resolved 2024-06-20 2024-09-20 231039
APO-LATANOPROST 50MCG SOLUTION Actual shortage 2024-12-12 2025-03-27 245508
APO-LATANOPROST 50MCG SOLUTION Resolved 2022-04-01 2022-09-23 157695
APO-LATANOPROST 50MCG SOLUTION Resolved 2017-03-10 2020-02-13 363
APO-LATANOPROST-TIMOP 5MG 50MCG SOLUTION Resolved 2017-03-13 2018-09-11 739
APO-LEFLUNOMIDE 10MG TABLET Resolved 2017-03-11 2017-05-23 667
APO-LEFLUNOMIDE 10MG TABLET Resolved 2024-01-19 2024-02-09 216659
APO-LEFLUNOMIDE 20MG TABLET Resolved 2024-04-26 2024-05-31 226315

Showing 1561 to 1580 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959

Showing 161 to 180 of 359